From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.13
First Reported 1993
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 1.80
Pain Relevance 0.89

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Il1f5) extracellular region (Il1f5) molecular_function (Il1f5)
biological_process (Il1f5)
Anatomy Link Frequency
platelets 2
Il1f5 (Mus musculus)
Pain Link Frequency Relevance Heat
Inflammation 35 98.76 Very High Very High Very High
dexamethasone 1 98.68 Very High Very High Very High
antagonist 3 92.80 High High
cINOD 4 91.80 High High
Antinociceptive 24 91.36 High High
Serotonin 8 90.80 High High
Inflammatory response 3 85.96 High High
anticonvulsant 1 83.04 Quite High
qutenza 12 5.00 Very Low Very Low Very Low
Pain 8 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 39 98.76 Very High Very High Very High
Pressure And Volume Under Development 15 98.64 Very High Very High Very High
Urological Neuroanatomy 3 98.24 Very High Very High Very High
Bacterial Respiratory Disease 1 80.48 Quite High
Fungal Infection 1 79.04 Quite High
Otitis 1 75.00 Quite High
Increased Venous Pressure Under Development 2 35.12 Quite Low
Malignant Neoplastic Disease 1 34.88 Quite Low
Peritonitis 8 28.84 Quite Low
Radiation Sickness 1 7.28 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A glucocorticoid (dexamethasone), two cyclooxygenase inhibitors (indomethacin, piroxicam) and an interleukin-1 (IL-1) release inhibitor (IX 207-887, Sandoz) all reduced edema and MPO activity as well.
Negative_regulation (inhibitor) of Localization (release) of interleukin-1 associated with pressure and volume under development, urological neuroanatomy and dexamethasone
1) Confidence 0.13 Published 1993 Journal Agents Actions Section Abstract Doc Link 8304241 Disease Relevance 0.98 Pain Relevance 0.47
These compounds can suppress antigen and mitogen-induced lymphocyte proliferation, natural-killer cell cytotoxicity, histamine release by mast cells, interleukin-1 (IL-1) secretion by human monocytes and the action of PAF on platelets [47].
Negative_regulation (suppress) of Localization (release) of interleukin-1 in platelets
2) Confidence 0.03 Published 2009 Journal Marine Drugs Section Body Doc Link PMC2810220 Disease Relevance 0.82 Pain Relevance 0.42

General Comments

This test has worked.

Personal tools